Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (MRA-HBV)
National Institutes of Health
Classification and identifiers
- Solicitation number
- FOR-AI-27-017
- Assistance listing (CFDA)
- 93.855
Amount
Amount not published by the funder
Who can apply
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by soliciting applications to support Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV (PLWH) and Hepatitis B Virus (HBV). This program will focus on: elucidating mechanisms of persistence and pathogenesis; discovering and developing clinically relevant biomarkers; discovering and/or validating host and/or new viral drug targets; and developing non-invasive diagnostics. Each MRA-HBV award will support an observational cohort paired with a multi-disciplinary teams focused on research that leverages samples from existing clinical data and sample repositories from previous cohort studies. Grant authorities that allow NIAID to forecast this opportunity are as follo...
Related opportunities
- Martin Delaney Collaboratories for HIV Cure ResearchNational Institutes of Health
- Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)National Institutes of HealthUp to $2.7M
- Mechanistic Exploration of Therapeutic Targets and Treatable Traits to Improve CNS Outcomes in People with HIVNational Institutes of Health
- NIH ARISE-HIV LAUNCH ChallengeNASA Tournament Lab (via HeroX)Closes in 31 daysUp to $1.0M
- Impact of Immunotherapies on CNS Outcomes in People with HIV: Potential Benefits, Challenges and RisksNational Institutes of Health
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)National Institutes of HealthCloses Mar 2027Up to $1.5M